TransCode Therapeutics, Inc.
RNAZ
$6.73
-$0.27-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.81M | 2.84M | 7.37M | 11.57M | 5.81M |
| Total Receivables | 953.10K | 198.30K | 176.10K | 322.40K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 318.00K | 476.20K | 90.80K | 211.00K | 342.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.90M | 1.24M | 600.00K | 941.80K | 940.00K |
| Total Current Assets | 21.98M | 4.75M | 8.24M | 13.04M | 7.09M |
|
|
|||||
| Total Current Assets | 21.98M | 4.75M | 8.24M | 13.04M | 7.09M |
| Net Property, Plant & Equipment | 370.70K | 19.90K | 24.70K | 38.10K | 89.30K |
| Long-term Investments | 25.74M | -- | -- | -- | -- |
| Goodwill | 25.74M | -- | -- | -- | -- |
| Total Other Intangibles | 114.30M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 455.70K | -- | 111.90K | 111.90K |
| Total Assets | 162.40M | 5.23M | 8.27M | 13.19M | 7.29M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 3.49M | 2.97M | 1.57M | 2.51M | 2.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 38.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 25.40K |
| Total Other Current Liabilities | -- | -- | -- | -- | 25.40K |
| Total Current Liabilities | 3.49M | 2.97M | 1.57M | 2.51M | 2.77M |
|
|
|||||
| Total Current Liabilities | 3.49M | 2.97M | 1.57M | 2.51M | 2.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.02M | 832.90K | 553.70K | 392.00K | 6.54M |
| Total Liabilities | 10.52M | 3.80M | 2.12M | 2.90M | 9.31M |
|
|
|||||
| Common Stock & APIC | 108.20M | 85.85M | 85.71M | 85.58M | 61.18M |
| Retained Earnings | -97.86M | -84.42M | -79.56M | -75.29M | -63.20M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.34M | 1.43M | 6.15M | 10.29M | -2.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 141.54M | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 141.54M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.34M | 1.43M | 6.15M | 10.29M | -2.02M |
| Total Preferred Equity | 141.54M | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 151.88M | 1.43M | 6.15M | 10.29M | -2.02M |
|
|
|||||